Stockscreener 앱 받기
16.14
3.99%
-0.67
시장 영업 전:
16.14
Anbio Biotechnology 주식(NNNN)의 최신 뉴스
Anbio Biotechnology Soars as Geopolitics Ignite Rebound - TipRanks
Why Anbio Biotechnology Class A Shares Are Sliding - TipRanks
Anbio Biotechnology (NNNN) director ZHANG MICHAEL W.C files initial Form 3 - Stock Titan
Director David H. Hsu files initial Form 3 at Anbio Biotechnology (NNNN) - Stock Titan
Why Anbio Biotechnology Shares Keep Sinking Today - TipRanks
Why Anbio Biotechnology Class A Shares Are Sinking - TipRanks
Anbio’s Stock Has Been On A Wild Run Since Its IPO - Finimize
Anbio Biotechnology (NNNN) Faces Sharp Pullback: Key Levels and Market Sentiment After 14.88% DeclinePercent Above MA - newsline.com
Anbio Biotechnology (NNNN) Drops 7.2% as Selling Pressure IntensifiesOpening Range Breakout - newsline.com
Why Anbio Biotechnology Class A Stock Is Sliding - TipRanks
Why Anbio Biotechnology NNNN Shares Are Surging Now - TipRanks
Why Anbio Biotechnology Shares Are Tumbling Today - TipRanks
Anbio Biotechnology Holds Steady Near $34.41 as Trading Volume Remains ModerateThrowback Trade - The Legal Advocate
Why Anbio Biotechnology Class A Shares Are Surging - TipRanks
Anbio Biotechnology (NNNN) Stock Forecast and Price Target 2026 - MarketBeat
Anbio Biotechnology (NNNN) Holds Near Support as Selling Pressure ModeratesAAII Bearish - newsline.com
Assessing Anbio Biotechnology (NNNN) Valuation After Strong Recent Share Price Momentum - simplywall.st
Anbio Biotechnology (NNNN) Share Price Forecast & Price Target - Investing.com UK
Why Anbio Biotechnology Shares Are Tumbling Now - TipRanks
Anbio Biotechnology Shareholders Approve Sweeping Capital and Governance Changes - TipRanks
Control shifts as Anbio (NNNN) boosts Class B voting power - Stock Titan
Why Anbio Biotechnology Shares Won’t Stop Climbing - TipRanks
Uncovering 3 Undiscovered Gems in the US Market - Yahoo Finance
Top Hemab Therapeutics (COAG) Competitors 2026 - MarketBeat
TradingKey - TradingKey
Number of shareholders of Anbio Biotechnology – NASDAQ:NNNN - TradingView
Why Anbio Biotechnology Class A Shares Keep Sliding - TipRanks
Why are smart money investors paying attention to Anbio (NNNN)? (Momentum Fading) 2026-05-07Overvalued Stocks - Newser
Hemab Therapeutics Hldgs (COAG) Stock Analysis Report | Financials & Insights - Benzinga
Why Anbio Biotechnology Class A Shares Are Jumping - TipRanks
Free cash flow per share of Anbio Biotechnology Class A – FWB:N3B - TradingView
Top LosersStock ScreenerSnapshot - Finviz
Anbio Biotechnology Calls May 15 Shareholder Votes on Sweeping Capital and Governance Overhaul - The Globe and Mail
Anbio Biotechnology (NNNN) seeks huge capital increase and 500-vote Class B shares - Stock Titan
Top Maplight Therapeutics (MPLT) Competitors 2026 - MarketBeat
Why Anbio Biotechnology Shares Are Suddenly Surging - TipRanks
Anbio (NNNN) Stock Volume Drop (Buying Pressure) 2026-04-22Swing Entry Signals - newsline.com
Anbio Biotechnology posts solid FY25 results, diversifies portfolio - MSN
Cany Xu Net Worth (2026) - GuruFocus
Nancy Hartzler Net Worth (2026) - GuruFocus
Suki Song Net Worth (2026) - GuruFocus
Michael Lau Net Worth (2026) - GuruFocus
Chris Tian Net Worth (2026) - GuruFocus
Why Anbio Biotechnology Shares Are Sliding Fast - TipRanks
Anbio Biotechnology (NASDAQ:NNNN) Trading Down 5.5%Here's What Happened - MarketBeat
Assessing Anbio Biotechnology (NNNN) Valuation After Sharp Swings And A Rich Price To Book Multiple - simplywall.st
Anbio Biotechnology Broadens Test Portfolio And Shifts Risk Profile - Sahm
Is Anbio (NNNN) Stock Discounted Now | Price at $27.63, Up 1.96%Day Trade Opportunities - newsline.com
Anbio Biotechnology Posts Solid FY25 Results, Diversifies Portfolio - Sahm
Is Anbio (NNNN) Stock Good for Beginners | Price at $26.77, Down 0.28%Retail Driven Moves - The Legal Advocate
1.68%
0.71%
자본화:
|
볼륨(24시간):